NO PBMs Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The NO PBMs Act (H.R. 5400) is a bill introduced in the 118th Congress aimed at addressing issues related to pharmacy benefit managers (PBMs) within the health policy area. The bill was referred to the Subcommittee on Health but did not advance further and is currently classified as failed or expired. There is no official summary or full text available for this bill, limiting detailed analysis of its provisions or intended effects.
H.R. 5400, the NO PBMs Act, sought legislative action concerning pharmacy benefit managers but did not progress beyond subcommittee referral and ultimately expired without enactment.
- The bill is titled NO PBMs Act and was introduced in the House of Representatives during the 118th Congress.
- It was referred to the Subcommittee on Health on December 17, 2024, but no further legislative action is recorded.
- The bill is categorized under the health policy area and is currently marked as failed or expired.
["Potential beneficiaries could include patients, healthcare providers, insurers, or pharmaceutical stakeholders depending on the bill's provisions, which are not available.", "The Subcommittee on Health and related health policy stakeholders might have had an interest in the bill's subject matter."]
['Lack of available bill text and official summary limits understanding of implementation challenges or cost implications.', 'Without detailed provisions, it is unclear what authority changes or oversight mechanisms the bill proposed.', 'The failure to advance beyond subcommittee referral suggests possible legislative or procedural hurdles.']
The bill was introduced during the 118th Congress and referred to the House Subcommittee on Health. The absence of further action and its failed/expired status indicate it did not gain sufficient legislative support or priority to move forward. The policy area of health often involves complex stakeholder interests, which may influence bill progression.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have influenced the roles and regulations surrounding pharmacy benefit managers, potentially affecting drug pricing and healthcare delivery.', 'Its failure to pass maintains the status quo in the health policy area related to PBMs.']
The absence of official summary and full text documentation reduces transparency and limits public and legislative oversight. Tracking the bill's referral to the Subcommittee on Health without further action highlights the importance of monitoring subcommittee proceedings for bill progress. The failed/expired status should be noted in future legislative tracking to avoid confusion about current law.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.